13F Filings for Crestline Management, LP (CIK: 1536054)
View the most recent portfolio holdings disclosed by Crestline Management, LP in their 13F filing.
Holding | Shares | Value | Portfolio Percent | Change Status | Change Amount |
---|---|---|---|---|---|
DNLI - DENALI THERAPEUTICS INC(Class: COM) | 3.86M | $54.01M | 86.33% | Decreased | 300K (7.0%, $2.55M) |
SANA - SANA BIOTECHNOLOGY INC(Class: COM) | 2.42M | $6.61M | 10.56% | Decreased | 370K (13.0%, $1.92M) |
EGHT - 8X8 INC NEW(Class: COM) | 990.58K | $1.94M | 3.10% | Unchanged |